… Somatostatin, a somatotropin release inhibiting factor (SST, … distributed multifunctional
cyclic peptide produced by cells … with the low degree of tumor differentiation, lymph node …

… as the somatotropin release-inhibiting factor/hormone (SRIF, SRIH) or … Thus, SST inhibits
glucagon secretion at low and high glucose … with tumor stage and lymph node metastasis [118]. …

… , where it is associated with increased lymph node metastasis, … (SS-14) that inhibited secretion
of the growth hormone in rat … (i) the extracellular domain containing 519 aa and consisting …

… -insulin-like growth factor 1 (IGF-1; a growth hormone … domain protein 2 activity (a FERM
domain-containing guanine … tissue as it contains no blood vessels or lymphatics and is not …

… peptide hormone-based therapy in various types of tumour treatments. Somatostatin (SST),
a growth hormone (GH)-inhibitory peptide, inhibits … low dose of glucocorticoids and inhibited …

… ; the non-CendR domain containing peptide (CRGDGGPDC) … the inhibition of growth
hormone secretion and inhibition of … Octreotide (SMS 201-995), an 8-mer cyclic peptide derived …

… The GH receptor (GHR) antagonist, B2036, effectively inhibits GH … coli when expressed
at low temperature. … adaptor protein Shc (src homology 2 domain containing transforming …

… T cells (Tregs), and low levels of TAMs are all generally … the accidental capture of axillary
lymph nodes as well. The … factor inhibition effects of AXT201 suggested that the peptide …

… metastasis in other organs such as bones and lymph nodes (3). In the … The native structure
of the growth hormone-releasing … is not a matrix metalloproteinase inhibitor or a mutagenic …

… escape, including the low immunogenicity of tumor cells, … widely distributed in the peripheral
blood, lymph nodes, spleen, … and reactive oxygen species to inhibit the activity of immune …